John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 450,000 shares at $4.56 ($2.1M) on 2024-05-13, disclosed to the SEC on 2024-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.58 | 150,000 | $687K | 33.4% |
| 2 | $4.56 | 150,000 | $684K | 33.3% |
| 3 | $4.56 | 150,000 | $684K | 33.3% |
| Total | $4.57 avg | 450,000 | $2.1M | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |